Kalt Derick A
MS Clinical Laboratory Management Program, Rush University, Chicago, Illinois.
Core Laboratory, Department of Pathology, Rush University Medical Center, Chicago, Illinois.
Lab Med. 2017 Nov 8;48(4):e62-e65. doi: 10.1093/labmed/lmx056.
Tacrolimus (Tac) is an immunosuppressive drug that is used in preventing organ and tissue rejection in patients after transplantation. Tac administration requires frequent and diligent monitoring by physicians to ensure proper dosage and to limit the potential for harmful adverse effects, which can include renal damage, neurotoxicity, and other serious adverse events. Tac is a calcineurin inhibitor, which suppresses the function of T-cells. Its success as an immunosuppressive agent has been well documented in preventing graft-vs-host disease in several types of organ transplants. This literature review will discuss Tac metabolism and its role in preventing tissue and organ transplant rejection. A variety of detection techniques used in the clinical laboratory, including dried-blood-spot analysis, liquid chromatography-tandem mass spectrometry, and immunoassay also will be discussed.
他克莫司(Tac)是一种免疫抑制药物,用于预防移植后患者的器官和组织排斥反应。使用他克莫司需要医生进行频繁且细致的监测,以确保剂量合适,并限制有害副作用的可能性,这些副作用可能包括肾损伤、神经毒性和其他严重不良事件。他克莫司是一种钙调神经磷酸酶抑制剂,可抑制T细胞的功能。其作为免疫抑制剂在预防多种器官移植中的移植物抗宿主病方面的成功已有充分记录。这篇文献综述将讨论他克莫司的代谢及其在预防组织和器官移植排斥反应中的作用。还将讨论临床实验室中使用的各种检测技术,包括干血斑分析、液相色谱 - 串联质谱法和免疫测定法。